Walgreens Boots Alliance Inc (WBA)
40.96
+0.35 (+0.86%)
USD |
NASDAQ |
May 20, 16:00
40.96
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 35.36B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -21.81% |
| Valuation | |
| PE Ratio | 5.650 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.2611 |
| Price to Book Value | 1.324 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.4775 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.4984 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 58.37% |
News
Headline
Wire
Time (ET)
Yahoo
05/20 08:00
Yahoo
05/19 17:50
SA Breaking News
05/16 13:04
Yahoo
05/15 08:44
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 07/01/2022* | -- | Results | Q3 2022 | -- | 0.94 | -- | |
| 07/01/2022* | 08:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 03/31/2022 | -- | Results | Q2 2022 | 1.59 | 1.40 | 13.76% | |
| 03/31/2022 | 08:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 01/06/2022 | -- | Results | Q1 2022 | 1.68 | 1.34 | 25.54% | |
| 01/06/2022 | 08:30 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 10/14/2021 | -- | Results | Q4 2021 | 1.17 | 1.02 | 14.59% | |
| 10/14/2021 | 08:30 EST | Earnings Call | Q4 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Walgreens Boots Alliance is a leading retail pharmacy chain, with over 13,000 stores in 50 states and 9 countries. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading market share of the domestic prescription drug market at about 20%. In 2021, the company sold off a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstores (40%). |
| URL | https://www.walgreens.com |
| Investor Relations URL | https://investor.walgreensbootsalliance.com |
| HQ State/Province | Illinois |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Jul. 01, 2022 (est.) |
| Last Earnings Release | Mar. 31, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 19, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 1.90 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 3.519 |
| Yield to Sector | 2.427 |
| Yield to Industry | 1.467 |
| Last Dividend Amt. | 0.4775 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | May. 19, 2022 |
| Yield (TTM) | 4.66% |
| Forward Yield | 4.66% |
| Payout Ratio | 26.12% |
| Cash Payout Ratio | 45.28% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of May 20, 2022.
Fundamentals
| Revenue (TTM) | 135.95B |
| Total Expenses (TTM) | 131.73B |
| Net Income (TTM) | 6.287B |
| Total Assets (Quarterly) | 92.68B |
| Total Liabilities (Quarterly) | 61.82B |
| Shareholders Equity (Quarterly) | 26.70B |
| Cash from Operations (TTM) | 5.183B |
| Cash from Investing (TTM) | 3.247B |
| Cash from Financing (TTM) | -7.62B |
Ratings
Profile
Edit
| Walgreens Boots Alliance is a leading retail pharmacy chain, with over 13,000 stores in 50 states and 9 countries. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading market share of the domestic prescription drug market at about 20%. In 2021, the company sold off a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstores (40%). |
| URL | https://www.walgreens.com |
| Investor Relations URL | https://investor.walgreensbootsalliance.com |
| HQ State/Province | Illinois |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Jul. 01, 2022 (est.) |
| Last Earnings Release | Mar. 31, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 19, 2022 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| RDIV | 36.27M USD | 4.61% |
| FXG | 22.29M USD | 3.92% |
| CAAIX | 46.28M USD | 3.30% |
| PKAAX | 35.12M USD | 2.73% |
| SVACX | 188.62M USD | 2.17% |
| SDY | 331.16M USD | 1.60% |
| XLP | 240.99M USD | 1.60% |
| FLKSX | 39.28M USD | 1.41% |
| VCSAX | 112.17M USD | 1.41% |
| FLPKX | 430.89M USD | 1.39% |
| VDC | 107.79M USD | 1.31% |
| VLUE | 96.87M USD | 0.96% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| WBA Tweets |